GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: ETX-2514 | EXT2514 | Xacduro® (sulbactam and durlobactam)
durlobactam is an approved drug (FDA (2023))
Compound class:
Synthetic organic
Comment: Durlobactam (ETX2514) is a broad-spectrum diazabicyclooctanone (DBO) class non-beta-lactam beta-lactamase inhibitor [1]. It reduces beta-lactamase-mediated degradation of beta-lactam antibacterials, and has been demonstrated to restore sulbactam activity against Acinetobacter species, including contemporary multidrug-resistant strains [4]. There is evidence that a few carbapenem- and colistin-resistant, metallo beta-lactamase (MBL)-producing strains of A. baumannii are resistant to sulbactam/durlobactam dual therapy [2,5].
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes. US FDA (2023) |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 10824 | durlobactam |
Synonyms ![]() |
| ETX-2514 | EXT2514 | Xacduro® (sulbactam and durlobactam) |
Database Links ![]() |
|
| Specialist databases | |
Antibiotic DB
|
Durlobactam |
| Other databases | |
| CAS Registry No. | 1467829-71-5 (source: WHO INN record) |
| ChEMBL Ligand | CHEMBL4298137 |
| DrugBank Ligand | DB16704 |
| GtoPdb PubChem SID | 483123241 |
| PubChem CID | 89851852 |
| Search Google for chemical match using the InChIKey | BISPBXFUKNXOQY-RITPCOANSA-N |
| Search Google for chemicals with the same backbone | BISPBXFUKNXOQY |
| Search PubMed clinical trials | durlobactam |
| Search PubMed titles | durlobactam |
| Search PubMed titles/abstracts | durlobactam |
| UniChem Compound Search for chemical match using the InChIKey | BISPBXFUKNXOQY-RITPCOANSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | BISPBXFUKNXOQY-RITPCOANSA-N |